|
|
40
|
|
|
A231H
|
|
|
GABANIL 300MG CAP (REM/SBI) GABAPENTIN
|
|
|
GABAPENTIN
|
|
|
GABANIL
|
|
|
5X10
|
|
|
C
|
|
|
9.51
|
|
|
0.19
|
|
|
300MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
REM
|
|
|
REMEDICA LTD
|
|
|
SBI
|
|
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
|
B
|
|
|
Anti-Epileptic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Yes
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|